In Vitro Fertilization for Polycystic Ovarian Syndrome

被引:1
|
作者
Zolton, Jessica R. [1 ]
Torrealday, Saioa [2 ]
机构
[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod Endocrinol & Gynecol, NIH, 10 Ctr Dr,Bldg 10,Room 8N248B,MSC 1840, Bethesda, MD 20892 USA
[2] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
来源
CLINICAL OBSTETRICS AND GYNECOLOGY | 2021年 / 64卷 / 01期
关键词
infertility; in vitro fertilization; polycystic ovarian syndrome; ovarian hyperstimulation syndrome; in vitro maturation; ASSISTED REPRODUCTIVE TECHNOLOGY; HYPERSTIMULATION SYNDROME; GNRH AGONIST; DOUBLE-BLIND; IVF; METFORMIN; WOMEN; MATURATION; STIMULATION; CYCLES;
D O I
10.1097/GRF.0000000000000561
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In vitro fertilization is indicated for infertile women with polycystic ovarian syndrome (PCOS) after unsuccessful treatment with ovulation induction agents or in women deemed high-risk of multiple gestations who are ideal candidates for single embryo transfers. PCOS patients are at increased risk of ovarian hyperstimulation syndrome; therefore, attention should be made in the choice of in vitro fertilization treatment protocol, dose of gonadotropin utilized, and regimen to achieve final oocyte maturation. Adopting these strategies in addition to close monitoring may significantly reduce the ovarian hyperstimulation syndrome risk. Future developments may improve pregnancy outcomes and decrease complications in PCOS women undergoing fertility treatment.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [1] In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome
    Colacurci, N
    Zullo, F
    DeFranciscis, P
    Mollo, A
    DePlacido, G
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (06) : 555 - 558
  • [2] Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization
    Vartanyan, E. V.
    Tsaturova, K. A.
    Devyatova, E. A.
    Mikhaylyukova, A. S.
    Levin, V. A.
    Petuhova, N. L.
    Markin, A. V.
    Steptsova, E. M.
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 : 8 - 11
  • [3] Perinatal Outcomes of Singletons Following In Vitro Fertilization in Women With Polycystic Ovarian Syndrome
    Estes, Jaclyn L.
    Pereira, Nigel
    Lekovich, Jovana
    Spandorfer, Steven D.
    OBSTETRICS AND GYNECOLOGY, 2016, 127 : 64S - 65S
  • [4] Pregnancy outcomes in women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF)
    Sterling, L.
    Liu, J.
    Sakhuja, A.
    Sierra, S.
    Okun, N.
    Greenblatt, E.
    HUMAN REPRODUCTION, 2015, 30 : 371 - 372
  • [5] Is in vitro fertilization the answer in polycystic ovary syndrome?
    Gupta, Sajal
    Sinha, Annika
    FERTILITY AND STERILITY, 2021, 115 (02) : 330 - 331
  • [6] INVITRO FERTILIZATION IN INFERTILE WOMEN WITH THE POLYCYSTIC OVARIAN SYNDROME
    DALE, PO
    TANBO, T
    ABYHOLM, T
    HUMAN REPRODUCTION, 1991, 6 (02) : 238 - 241
  • [7] Risk factors for low oocyte retrieval in patients with polycystic ovarian syndrome undergoing in vitro fertilization
    Jin, Hao
    Yang, Haiyan
    Zheng, Jiujia
    Zhou, Jiechun
    Yu, Rong
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2023, 21 (01)
  • [8] Outcomes of in vitro fertilization cycles among patients with polycystic ovary syndrome following ovarian puncture for in vitro maturation
    Lin, Jia
    Wang, Peiyu
    Zhao, Junzhao
    Xiao, Shiquan
    Yu, Rong
    Jin, Congcong
    Zhu, Ruru
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 135 (03) : 319 - 323
  • [9] Impact of high body mass index with or without polycystic ovarian syndrome on the outcome of in vitro fertilization
    Jin, Hao
    Huang, Xuefeng
    Lin, Jinju
    Jin, Congcong
    Teng, Yill
    Yu, Rong
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (06) : 852 - 856
  • [10] Risk factors for low oocyte retrieval in patients with polycystic ovarian syndrome undergoing in vitro fertilization
    Hao Jin
    Haiyan Yang
    Jiujia Zheng
    Jiechun Zhou
    Rong Yu
    Reproductive Biology and Endocrinology, 21